drugset / Trial / NCT06221241
Evaluate the Efficacy and Safety of JMKX000623 in Participants With Diabetic Peripheral Neuropathic Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 2, Multicenter, Randomized, Double-blind, Placebo and Active Drug-controlled Trial to Evaluate the Efficacy and Safety of JMKX000623 in Participants with Diabetic Peripheral Neuropathic Pain
Timeline
- Start
- 2024-03-25
- Primary completion
- 2025-03-14
- Completion
- 2025-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JMKX000623 | Unknown | — | Oral |
| Comparator | Pregabalin | Small molecule | — | Oral |